Medical 21, Inc. — Regulation A 1-A/A
Medical 21, Inc. of Plymouth, MN filed a Regulation A 1-A/A with the SEC on 2022-04-22. Aggregate offering: $40.0M (Tier 2). Industry: Other.
Offering
- Filed: 2022-04-22
- Form: 1-A/A
- Accession: 0001673688-22-000006
- Tier: Tier 2
- Total aggregate offering: $40.0M
- Issuer portion: $40.0M
- Price per security: $5.8000
- Securities offered: Equity (common or preferred stock)
- Audit status: Audited
- Auditor: Assurance Dimensions
- Jurisdictions: 128 states/territories
Issuer
- CIK: 0001673688
- Organized in: MN
- Incorporated: 2016
- Address: 3700 Annapolis Lane N Ste 105, Plymouth, MN, 55447
- Phone: 6124297630
- Employees: 7 full-time
Financial snapshot (as filed)
- Total assets: $4.6M
- Cash & equivalents: $3.5M
- Total liabilities: $150K
- Stockholder equity: $4.5M
- Net income: $-3.9M
People (2)
| Name | Role | Location |
|---|
| Nicholas Antaki | Signer | SCOTTSDALE, AZ |
| Dr. Manny Villifana | DIRECTOR, CEO | Plymouth, MN |
Other Reg A filings by this issuer (6)
More